Advertisement
YOU ARE HERE: LAT HomeCollectionsSmith Laboratories Inc
IN THE NEWS

Smith Laboratories Inc

FEATURED ARTICLES
BUSINESS
May 27, 1987
Smith Laboratories Inc. reported $278,000 in net income and $2.4 million in revenue for the second quarter ended April 30. The San Diego-based medical products company reported a $112,000 net loss and $2.3 million in revenue during the same quarter a year ago. Smith moved to San Diego from Chicago last September. Its Sutter Biomedical Inc. subsidiary is located in Kearny Mesa. Sutter manufactures orthopedic implants and rehabilitation devices.
ARTICLES BY DATE
Advertisement
BUSINESS
May 27, 1987
Smith Laboratories Inc. reported $278,000 in net income and $2.4 million in revenue for the second quarter ended April 30. The San Diego-based medical products company reported a $112,000 net loss and $2.3 million in revenue during the same quarter a year ago. Smith moved to San Diego from Chicago last September. Its Sutter Biomedical Inc. subsidiary is located in Kearny Mesa. Sutter manufactures orthopedic implants and rehabilitation devices.
BUSINESS
July 3, 2002 | Associated Press
A judge dismissed Federal Trade Commission charges that Schering-Plough Corp. and Upsher-Smith Laboratories Inc. colluded to set prices for a blood pressure drug. The decision by an FTC administrative law judge is a defeat for the FTC's concerted push against what it sees as a pattern of anti-competitive practices within the drug industry that is keeping cheap generics off the market.
BUSINESS
March 10, 2005 | From Reuters
An appeals court sided with Schering-Plough Corp., rejecting a finding by U.S. antitrust enforcers that the company illegally kept less expensive versions of the high blood pressure drug K-Dur off the market. A three-judge panel of the U.S. 11th Circuit Court of Appeals in Atlanta on Tuesday rejected a 2003 Federal Trade Commission ruling that Schering-Plough's settlements of patent suits with Upsher-Smith Laboratories Inc.
Los Angeles Times Articles
|